Oncology News and Research

RSS

Oncology, meaning bulk, mass, or tumor, and the suffix ''-logy'', meaning "study of") is a branch of medicine that deals with tumors (cancer). A medical professional who practices oncology is an ''oncologist''.

Adagrasib shows promise for the treatment of patients with KRAS G12C-mutated non-small cell lung cancer

Researchers from The University of Texas MD Anderson Cancer Center found the KRAS G12C inhibitor adagrasib showed promising activity suppressing cancer growth not only within the lungs but also in brain metastases for patients with KRAS G12C-mutated non-small cell lung cancer.

16 Jun 2023

NCCN guidelines establish an equitable standard of care for cancer outcomes

Today, the National Comprehensive Cancer Network® (NCCN®) - an alliance of leading cancer centers - convened a policy summit to examine how geography impacts cancer outcomes.

16 Jun 2023

$Fruquintinib improved survival in patients with refractory metastatic colorectal cancer$

Fruquintinib improved survival in patients with refractory metastatic colorectal cancer

Researchers from The University of Texas MD Anderson Cancer Center reported study results showing that the targeted therapy fruquintinib significantly improved overall survival (OS) and progression-free survival (PFS) in patients with refractory metastatic colorectal cancer.

16 Jun 2023

No improvement in freedom from progression rates for patients: Study

Results from the NRG Oncology NRG-RTOG 0232 clinical trial adding external beam radiotherapy (EBRT) to brachytherapy (BT) in men with intermediate-risk prostate cancer indicate that there was no improvement in freedom from progression (FFP) rates for patients.

16 Jun 2023

New selective targeted therapy for metastatic colorectal cancer prolongs overall survival

A new therapy is on the horizon for patients with metastatic colorectal cancer who have run out of treatment options.

16 Jun 2023

Complete genomics announces updated mission and new partnerships on 18th anniversary

Complete Genomics, Inc., a pioneering genomics company, today unveiled updated mission/vision statement to reflect renewed ambitions in taking on more for a better world, in celebration of its 18th anniversary.

From MGI 15 Jun 2023

New atraumatic uterine manipulator for minimally invasive gynecological surgery

Asociación RUVID Researchers from the Biomechanics and Ergonomics research group of the Universitat Jaume I, the Abdomino-Pelvic Oncology Surgery Referral Unit (UR-COAP) of the General University Hospital of Castelló and the Fisabio Foundation have developed an atraumatic uterine manipulator for minimally invasive gynaecological surgery.

15 Jun 2023

Analyzing the role of ACSL4 in quadruple negative breast cancer

A new review paper was published in Oncotarget's Volume 14 on June 12, 2023, entitled, "ACSL4: biomarker, mediator and target in quadruple negative breast cancer."

15 Jun 2023

Older breast cancer survivors show greater epigenetic aging than same-aged people without cancer

In a new multi-center study, researchers from the Medical College of Wisconsin (MCW) joined with leading cancer centers from across the nation to examine whether cancer and its treatments accelerate aging.

14 Jun 2023

NCCN introduces new global resource to improve thyroid cancer care in low- and middle-income countries

The National Comprehensive Cancer Network® (NCCN®) is introducing a new global resource to improve thyroid cancer care in low- and middle-income countries at the upcoming World Congress on Thyroid Cancer, in London. During the event, NCCN Senior Vice President and Chief Medical Officer, Wui-Jin Koh, MD, will present on NCCN's ongoing global work to define and advance high-quality, high-value, patient-centered cancer care.

14 Jun 2023

Mark Cuban's Cost Plus Drug Company projects huge savings over Medicare for generic cancer medications

Researchers reveal significant cost savings when generic oncology drugs are purchased through the Mark Cuban Cost Plus Drug Company.

13 Jun 2023

Automated liquid biopsy test predicts early disease progression, survival among patients with metastatic breast cancer

A novel, automated liquid biopsy test in development by researchers at the Johns Hopkins Kimmel Cancer Center can be used to predict early disease progression and potential survival among patients with metastatic breast cancer in as little as one month after starting treatment, according to a recent study.

13 Jun 2023

Study provides a new and promising strategy for future cancer immunotherapies

CD8+ T cells, a vital component of the immune system that provides immunity against cancer, have been the focal point of anti-cancer therapies.

13 Jun 2023

Analyzing the role of LP-284 Hodgkin's lymphoma models and in DNA damage repair

A new research paper was published in Oncotarget's Volume 14 on June 12, 2023, entitled, "LP-284, a small molecule acylfulvene, exerts potent antitumor activity in preclinical non-Hodgkin's lymphoma models and in cells deficient in DNA damage repair."

13 Jun 2023

Manipulating white blood cells to eliminate solid tumors

By silencing the molecular pathway that prevents macrophages from attacking our own cells, Penn Engineers have manipulated these white blood cells to eliminate solid tumors.

12 Jun 2023

Researchers identify a potential breakthrough in glioblastoma treatment

In a recently published manuscript, Howard Colman, MD, PhD, Jon M. Huntsman Presidential Professor of Neuro-Oncology and co-leader of the Neurologic Cancers Disease Center and the Experimental Therapeutics CCSG program at Huntsman Cancer Institute, identified a potential breakthrough in glioblastoma treatment.

12 Jun 2023

Researchers discover how a sugar molecule can affect cancer cell response to chemoradiotherapy

Researchers at Georgetown University's Lombardi Comprehensive Cancer Center and colleagues who have been exploring the complexities of biochemical pathways involved in cancer development have found that a form of glucose, a type of sugar, is intricately linked to a pathway used to build DNA molecules.

12 Jun 2023

Study: Gentle cleansers just as effective as harsh soaps in killing viruses

Gentle cleansers are just as effective in killing viruses - including coronavirus - as harsh soaps, a new study by University of Sheffield experts has found.

11 Jun 2023

Genetic counselling for familial colorectal cancer provides improves patients' feelings of empowerment

Genetic counselling is essential when dealing with individuals who are affected by, or at risk of, inherited disease.

11 Jun 2023

Keynote speakers of ELRIG Drug Discovery 2023 announced

The European Laboratory Research & Innovation Group (ELRIG) UK today announced the keynote speakers for Drug Discovery 2023, taking place at the ACC in Liverpool from 18–19 October. Prof Janet Hemingway CBE, FRS, Founding Director of Infection Innovation Consortium (iiCON), and Dr Dave Powell, Chief Scientific Officer (CSO) of LifeArc will lead this year’s event focussing on diverse thinking and new perspectives.

10 Jun 2023

Oncology News and Research

Further Reading

Adagrasib shows promise for the treatment of patients with KRAS G12C-mutated non-small cell lung cancer

NCCN guidelines establish an equitable standard of care for cancer outcomes

Fruquintinib improved survival in patients with refractory metastatic colorectal cancer

No improvement in freedom from progression rates for patients: Study

New selective targeted therapy for metastatic colorectal cancer prolongs overall survival

Complete genomics announces updated mission and new partnerships on 18th anniversary

New atraumatic uterine manipulator for minimally invasive gynecological surgery

Analyzing the role of ACSL4 in quadruple negative breast cancer

Older breast cancer survivors show greater epigenetic aging than same-aged people without cancer

NCCN introduces new global resource to improve thyroid cancer care in low- and middle-income countries

Mark Cuban's Cost Plus Drug Company projects huge savings over Medicare for generic cancer medications

Automated liquid biopsy test predicts early disease progression, survival among patients with metastatic breast cancer

Study provides a new and promising strategy for future cancer immunotherapies

Analyzing the role of LP-284 Hodgkin's lymphoma models and in DNA damage repair

Manipulating white blood cells to eliminate solid tumors

Researchers identify a potential breakthrough in glioblastoma treatment

Researchers discover how a sugar molecule can affect cancer cell response to chemoradiotherapy

Study: Gentle cleansers just as effective as harsh soaps in killing viruses

Genetic counselling for familial colorectal cancer provides improves patients' feelings of empowerment

Keynote speakers of ELRIG Drug Discovery 2023 announced

A best-practice guide for laboratory services in oncology trials eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News